Research Paper Volume 16, Issue 1 pp 129—152
Systematic analysis of the prognostic value and immunological function of LTBR in human cancer
Figure 4. The relationship of LTBR expression with patients’ PFI, DSS, DFI, and clinical stage. Forest plots of hazard ratios of LTBR in (A) PFI, (B) DSS, and (C) DFI. (D–K) Pan-cancer differential expression of LTBR in clinical stages.